Showing results (3121-3130 of 11,196) with videos related to
Sort By:
Pageof 1,120
Journal of Neurology|November 19, 2004
Importance of benefit-to-risk assessment for disease-modifying drugs used to treat MSGordon S FrancisJournal of Neurology|November 19, 2004
Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?Ludwig Kappos, Jens Kuhle, Achim Gass, et al.Journal of Neurology|February 1, 1992
Dystrophin deficiency in a case of congenital myopathyA Prelle, R Medori, M Moggio, et al.Journal of Neurology|February 1, 1992
Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymomaY Fujii, M Hayakawa, K NakaharaJournal of Neurology|February 1, 1992
Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory studyK Lauer, W FirnhaberJournal of Neurology|October 27, 2004
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosisGiovanni Savettieri, Demetrio Messina, Virginia Andreoli, et al.Journal of Neurology|October 27, 2004
Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissectionsCarsten Konrad, Georg A Müller, Claus Langer, et al.Journal of Neurology|October 27, 2004
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathiesK Hahn, G Arendt, J S Braun, et al.Journal of Neurology|June 9, 2005
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-upEster Reggio, Alessandra Nicoletti, Teresa Fiorilla, et al.Journal of Neurology|May 1, 1992
Monitoring of somatosensory evoked potentials during carotid endarterectomyA Amantini, M Bartelli, G de Scisciolo, et al.Pageof 1,120